Simply said, we grow mini-organs, or organoids from patient biopsies or reactions. These organoids serve as valuable tools to assist our clients in their research endeavors. For example, we help drug developers to assess the therapeutic potential of their drug candidates. One of the benefits of our technology is that it allows us to derive new models directly from patient tissue. This ensures greater genetic and physiological relevance, minimizes the use of animals in drug development, and enables us to accurately predict patient response to treatment. Our ultimate goal is to bring every ‘patient in the lab’, to evaluate treatment strategies before implementing them in the clinic.